Effect of demographic characteristics, clinical phenotype, and fibrinogen supplementation on the total HRQoL score according to multivariate analysis
| Variable . | Mean difference in HRQoL total score . | P . | 95% CI . |
|---|---|---|---|
| Age, adult | −5.7 | .018 | −10.4; −1.0 |
| Male | 2.0 | .369 | −2.4; 6.5 |
| Continent, Asia-Africa | 10.6 | <.001 | 4.9; 16.4 |
| Distance from treatment center >100 km | −3.7 | .130 | −8.6; 1.1 |
| ISTH BAT (continuous) | 0.2 | .038 | 0.0; 0.5 |
| Thrombotic phenotype | 7.5 | .017 | 1.4; 13.6 |
| Availability of fibrinogen concentrate or cryoprecipitate | −6.8 | .108 | −15.1; 1.5 |
| Variable . | Mean difference in HRQoL total score . | P . | 95% CI . |
|---|---|---|---|
| Age, adult | −5.7 | .018 | −10.4; −1.0 |
| Male | 2.0 | .369 | −2.4; 6.5 |
| Continent, Asia-Africa | 10.6 | <.001 | 4.9; 16.4 |
| Distance from treatment center >100 km | −3.7 | .130 | −8.6; 1.1 |
| ISTH BAT (continuous) | 0.2 | .038 | 0.0; 0.5 |
| Thrombotic phenotype | 7.5 | .017 | 1.4; 13.6 |
| Availability of fibrinogen concentrate or cryoprecipitate | −6.8 | .108 | −15.1; 1.5 |
CI, confidence interval.